Debbie Hart – Founding President & CEO, BioNJ, USA

16.10.2019
BioNJ’s president and CEO Debbie Hart reflects on the association’s mission of creating a robust and engaging life sciences ecosystem in New Jersey. Hart also outlines how BioNJ is hoping to continue to grow the region’s reputation as a hub that stands out for its level of expertise, favourable geographic location, and supportive governmental initiatives.  
Much of the research, the development and the manufacturing that is happening in [the cell and gene therapy] space is happening right here in New Jersey
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
USA, BioNJ, Association, Research, Cell & Gene Therapy, Innovation, Investment

Related Interviews

Melanie Croce-Galis – Director, US Patient Engagement, Oncology, Novartis

Melanie Croce-Galis, RN, MPH explains the specificities of her work as patient engagement lead for Novartis Oncology in the US market, where significant disparities in patient access to information and…

Paediatric Oncology / Dr Navin Pinto on CAR-T's Potential

Paediatric oncologist Navin Pinto, MD outlines the current use and potential of CAR-T therapies in his field, including the manufacturing challenges that still need to be addressed. Dr Pinto also…

Claire Saxton – Vice President, Patient Experience & Lauren Kriegel…

Claire Saxton and Lauren Kriegel of Cancer Support Community, the largest professionally led non-profit network of cancer support worldwide, discuss how cancer patient and caregiver perspectives need to be better…

Related Articles

CAR-T / Patient Engagement Roundtable: A Varied Global Picture

As complex cutting-edge therapies come online, industry sponsors are increasingly looking to engage with patients, caregivers, and advocacy groups earlier and more broadly in the drug development process to better…

Investment / J.P. Morgan Healthcare Conference 2022: Glass Half Full

David H. Crean summarizes the recent 40th annual J.P. Morgan Healthcare Conference 2022 that was held in a virtual format. Crean underlines the importance of the Conference for establishing the tone…

Top 10 Global Pharma Markets Ranking

Based on IQVIA’s pharma market rankings for 2020, we give a rundown of the global top 10, key companies, important trends, and where you can go to learn more.  …

Latest Report

Saudi Arabia Pharma Report 2022

Related Content

USA
BioNJ
Association
Research
Cell & Gene Therapy
Innovation
Investment